Table 2. Other annual costs of DM management in B&H.
Type of costs | Annual costs per patient | Percent of affected patients | Annual costs for whole B&H population of DM patients |
---|---|---|---|
Medication costs (ATC -A10) | 157.87 € | NA | 40,417,530 € |
Glucose measuring instruments | 0.34 € | NA | 87,459 € |
Accessories for glucose measuring instruments | 0.01 € | NA | 1,487 € |
Glucose test stripes | 13.39 € | NA | 3,427,304 € |
Costs of complications: diabetic foot | 4727.73 € | 0.48% | 5,759,556 € |
Costs of Complications: end-stage renal disease (ESRD) | 696.56 € | 0.05% | 88,394 € |
Costs of Complications: heart failure | 1268.8 € | 4.40% | 14,169,057 € |
Costs of Complications: painful neuropathy | 366.74 € | 3.42% | 3,183,314 € |
Costs of Complications: peripheral vascular disease | 2535.18 € | 0.27% | 1,737,271 € |
Costs of Complications: retinopathy | 287.76 € | 0.56% | 408,991 € |
Costs of Complications: stable angina | 1629.01 € | 6.15% | 25,426,933 € |
Total costs of DM without complications | 319.0 € | NA | 81,580,901 € |
Total costs of DM with complications | 516.97 € | NA | 132,354,418 € |
Loss of productivity costs | 222.0 € | NA | 56,723,322 € |
Total costs of DM in B&H | 738.97 € | NA | 189,077,740 € |